Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Novalis Biotech
AddedFeb 15, 2024
UpdatedJun 28, 2026
Novalis Biotech

Novalis Biotech

Operating

Novalis Biotech Incubation: Seeding and funding early-stage biotech startups for stakeholder value.

Location
Ghent, East Flanders, BE
Founded
2018
Firm
Compare
Portfolio
Employees
Website

Novalis Biotech Incubation focuses on seeding and funding early-stage biotechnology and life sciences startups. They typically invest in seed rounds, providing essential capital to help nascent companies grow and develop their business strategies. By leveraging their professional and academic connections, Novalis Biotech aims to create significant value for all stakeholders involved.

Notable portfolio companies include Modality.AI, which has raised over $3.6 million, and Alithea Genomics, a leader in large-scale RNA sequencing and transcriptomics. Novalis Biotech's investment philosophy centers on nurturing innovation in the biotech sector, offering not just financial support but also strategic guidance and industry connections to help startups succeed.

Novalis Biotech - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments2
Current Portfolio Count1
Total Portfolio Exits0

Top Investment Stages

Seed2 (100.0%)

Stage Mix

Seed 100%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Modality.AI logo

Modality.AI

Novalis Biotech - Similar Investment Firms

Novalis LifeSciences logo

Novalis LifeSciences

Emerald Bioventures logo

Emerald Bioventures

RebelBio logo

RebelBio

sosv.com

Viva BioInnovator logo

Viva BioInnovator

vivabiotech.com

Novo Seeds logo

Novo Seeds

LongeVC logo

LongeVC

longevc.com

Vesper Ventures logo

Vesper Ventures

vesper-bio.com

Angelwise logo

Angelwise

angelwise.be

Propagator Ventures logo

Propagator Ventures

propagator.vc

Petri logo

Petri

petri.bio

Woodside Incubator logo

Woodside Incubator

Alix Ventures logo

Alix Ventures

alix.vc

Genesis Accel logo

Genesis Accel

genesisaccel.com

BioInnovation logo

BioInnovation

Alta Life Sciences logo

Alta Life Sciences

altals.com

Novalis Biotech - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 2 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services